New evidence for teriflunomide in multiple sclerosis

被引：3
|
作者：
Kieseier, Bernd C. [1 ]
Wiendl, Heinz [2 ]
机构：
[1] Univ Dusseldorf, Dept Neurol, Fac Med, D-40225 Dusseldorf, Germany
[2] Univ Munster, Dept Neurol, D-48149 Munster, Germany
来源：
LANCET NEUROLOGY | 2014年 / 13卷 / 03期
关键词：
ORAL FINGOLIMOD;
D O I：
10.1016/S1474-4422(14)70012-2
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：234 / 235
页数：2
相关论文
共 50 条
  • [41] Vaccine Response in Patients With Multiple Sclerosis Receiving Teriflunomide
    Tornatore, Carlo
    Wiendl, Heinz
    Lublin, Alex L.
    Geertsen, Svend S.
    Chavin, Jeffrey
    Truffinet, Philippe
    Bar-Or, Amit
    [J]. FRONTIERS IN NEUROLOGY, 2022, 13
  • [42] Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis
    Moreira Ferreira, Vanessa F.
    Caefer, Danielle
    Erlich-Malona, Natalie
    Healy, Brian C.
    Chitnis, Tanuja
    Stankiewicz, James M.
    [J]. MULTIPLE SCLEROSIS INTERNATIONAL, 2020, 2020
  • [43] An updated review of teriflunomide's use in multiple sclerosis
    Miller, Aaron E.
    [J]. NEURODEGENERATIVE DISEASE MANAGEMENT, 2021, 11 (05) : 387 - 409
  • [44] Predictive Factors of Response to Teriflunomide in Patients with Multiple Sclerosis
    Aguirre, C.
    Meca-Lallana, V.
    Diaz-Perez, C.
    del Rio, B.
    Carabajal, E.
    Vivancos, J.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (1_SUPPL) : 175 - 175
  • [45] Randomized Trial of Oral Teriflunomide for Relapsing Multiple Sclerosis
    O'Connor, Paul
    Wolinsky, Jerry S.
    Confavreux, Christian
    Comi, Giancarlo
    Kappos, Ludwig
    Olsson, Tomas P.
    Benzerdjeb, Hadj
    Truffinet, Philippe
    Wang, Lin
    Miller, Aaron
    Freedman, Mark S.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (14): : 1293 - 1303
  • [46] Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis
    Kalincik, Tomas
    Havrdova, Eva Kubala
    Horakova, Dana
    Izquierdo, Guillermo
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Onofrj, Marco
    Lugaresi, Alessandra
    Ozakbas, Serkan
    Kappos, Ludwig
    Kuhle, Jens
    Terzi, Murat
    Lechner-Scott, Jeannette
    Boz, Cavit
    Grand'Maison, Francois
    Prevost, Julie
    Sola, Patrizia
    Ferraro, Diana
    Granella, Franco
    Trojano, Maria
    Bergamaschi, Roberto
    Pucci, Eugenio
    Turkoglu, Recai
    McCombe, Pamela A.
    Van Pesch, Vincent
    Van Wijmeersch, Bart
    Solaro, Claudio
    Ramo-Tello, Cristina
    Slee, Mark
    Alroughani, Raed
    Yamout, Bassem
    Shaygannejad, Vahid
    Spitaleri, Daniele
    Luis Sanchez-Menoyo, Jose
    Ampapa, Radek
    Hodgkinson, Suzanne
    Karabudak, Rana
    Butler, Ernest
    Vucic, Steve
    Jokubaitis, Vilija
    Spelman, Tim
    Butzkueven, Helmut
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (04): : 458 - 468
  • [47] Disability stabilization in multiple sclerosis under teriflunomide treatment
    Sangalli, F.
    Pisa, M.
    Radaelli, M.
    Moiola, L.
    Colombo, B.
    Dalla Costa, G.
    Esposito, F.
    Comi, G.
    Martinelli, V.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 915 - 916
  • [48] Teriflunomide: A Review of Its Use in Relapsing Multiple Sclerosis
    Karly P. Garnock-Jones
    [J]. CNS Drugs, 2013, 27 : 1103 - 1123
  • [49] Teriflunomide Associated Aggressive Rebound Syndrome In Multiple Sclerosis
    Abdalla, K.
    Prabhu, A.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (1_SUPPL) : 70 - 70
  • [50] Psoriasiform eruption caused by teriflunomide in a patient with multiple sclerosis
    Agirgol, Senay
    Kurtuncu, Murat
    Gurbuzel, Mihriban
    Tasyurek, Ilay
    Gunduz, Tuncay
    [J]. CLINICAL TOXICOLOGY, 2019, 57 (11) : 1125 - 1127
12345